Pradaxa (dabigatran etexilate) is the first oral direct thrombin inhibitor to be approved by the FDA.
Zachary Yuschock, PharmD Candidate
Advertisement
Articles by Zachary Yuschock, PharmD Candidate
Advertisement
Latest Updated Articles
- Boehringer Ingelheim Pharmaceuticals' Pradaxa
Published: December 13th 2010 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times
1
A Common Virus May Hold New Clues to Lupus
2
SHR-A1811 Plus Pertuzumab Improves Survival in HER2-Positive Metastatic Breast Cancer
3
FDA Approves Poherdy, First Biosimilar to Perjeta, For HER2 Breast Cancer Indications
4
When to Call, When to Counsel: Statin Drug Interactions
5
